What happened in this Tech story?

The OpenAI Foundation launched 'Data for Public Health,' with initial grants including $40M for cancer vaccine data at UNC Chapel Hill and $500K to 1Day Sooner for acquiring regulatory filings from bankrupt biotech companies to train medical AI.

What is a key fact in this story? (1)

**OpenAI Foundation** launched 'Data for Public Health' to fund high-quality scientific datasets, arguing that data is the biggest bottleneck for AI in biology — a view echoed by former Altos Labs VP Morgan Levine.

What is a key fact in this story? (2)

The foundation's first grants include **$40 million** to the University of North Carolina, Chapel Hill for novel cancer vaccine data collection, plus support for OpenAdmet, which runs drug-effect prediction competitions.

📎 SkimNews has covered OpenAI 445+ times · see the file →

OpenAI Foundation bets bankrupt biotechs hold AI training gold — SkimNews

By MIT Technology Review · Summarized & edited by Kapil Samant · 2026-09-15

Get the Tech newsletter

Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.

OpenAI Foundation launched 'Data for Public Health' to fund high-quality scientific datasets, arguing that data is the biggest bottleneck for AI in biology — a view echoed by former Altos Labs VP Morgan Levine.
The foundation's first grants include $40 million to the University of North Carolina, Chapel Hill for novel cancer vaccine data collection, plus support for OpenAdmet, which runs drug-effect prediction competitions.
1Day Sooner received $500,000 to pursue Ruxandra Teslo's 'biotech's lost archive' concept — buying regulatory filings, manufacturing strategies, and safety data from bankrupt biotech companies, documents normally treated as trade secrets.
1Day Sooner already holds three datasets (two donated by Lumen Bioscience) and estimates nonexclusive copies of company files could be acquired for 'a few tens of thousands of dollars' each, though two acquisition bids failed this year.
The OpenAI Foundation holds a 26% equity stake in the for-profit OpenAI — potentially worth $250 billion — and aims to give away $1 billion by year's end; its largest prior gift was $100M to the Common Health Coalition in August.
Foundation executive Jacob Trefethen says the foundation operates independently from OpenAI but shares the mission of ensuring AI 'benefits all of humanity,' even as Sam Altman and Elon Musk last week endorsed Anthropic CEO Dario Amodei's call to slow AI capability gains.

Why it matters: The bankrupt-biotech-archive model turns failed companies' trade-secret regulatory filings into AI training fuel at a price Teslo estimates at 'a few tens of thousands of dollars' per dataset. If 1Day Sooner closes more deals, medical AIs could soon know far more about the 70% of drug-development time and money currently spent in opaque clinical trials — the very process Teslo calls 'basically a black box' for small biotechs.